These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23887295)

  • 1. P16 but not retinoblastoma expression is related to clinical outcome in no-special-type triple-negative breast carcinomas.
    Bogina GS; Lunardi G; Marcolini L; Brunelli M; Bortesi L; Marconi M; Coati F; Valerio M; Guerriero M; Massocco A; Pegoraro MC; Zamboni G
    Mod Pathol; 2014 Feb; 27(2):204-13. PubMed ID: 23887295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically.
    Subhawong AP; Subhawong T; Nassar H; Kouprina N; Begum S; Vang R; Westra WH; Argani P
    Am J Surg Pathol; 2009 Feb; 33(2):163-75. PubMed ID: 18936692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.
    Igarashi T; Jiang SX; Kameya T; Asamura H; Sato Y; Nagai K; Okayasu I
    Mod Pathol; 2004 Oct; 17(10):1259-67. PubMed ID: 15154011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 expression is increased in p16-expressing triple-negative breast carcinoma and correlates with p16 only in p53-negative tumors.
    Sugianto J; Sarode V; Peng Y
    Hum Pathol; 2014 Apr; 45(4):802-9. PubMed ID: 24560018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas.
    Ghazizadeh M; Jin E; Shimizu H; Fujiwara M; Arai S; Ohaki Y; Takemura T; Kawanami O
    Respiration; 2005; 72(1):68-73. PubMed ID: 15753637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma.
    Jayasurya R; Sathyan KM; Lakshminarayanan K; Abraham T; Nalinakumari KR; Abraham EK; Nair MK; Kannan S
    Mod Pathol; 2005 Aug; 18(8):1056-66. PubMed ID: 15731778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy.
    Gavressea T; Kalogeras KT; Koliou GA; Zagouri F; Lazaridis G; Gogas H; Tsigaridas K; Koutras A; Petraki K; Markopoulos C; Pazarli E; Aravantinos G; Papadimitriou C; Papakostas P; Koufopoulos N; Karanikiotis C; Chrisafi S; Kalofonos HP; Pectasides D; Fountzilas G; Pavlakis K
    Anticancer Res; 2017 Jun; 37(6):2947-2957. PubMed ID: 28551632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications.
    El-Naggar AK; Lai S; Clayman GL; Zhou JH; Tucker SA; Myers J; Luna MA; Benedict WF
    Hum Pathol; 1999 Sep; 30(9):1013-8. PubMed ID: 10492034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers.
    Hommura F; Dosaka-Akita H; Kinoshita I; Mishina T; Hiroumi H; Ogura S; Katoh H; Kawakami Y
    Br J Cancer; 1999 Oct; 81(4):696-701. PubMed ID: 10574258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p16 and pRB in invasive breast cancer.
    Shin E; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2015; 8(7):8209-17. PubMed ID: 26339389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Rb, p16, and p53 expression is specific for porocarcinoma relative to poroma.
    Zahn J; Chan MP; Wang G; Patel RM; Andea AA; Bresler SC; Harms PW
    J Cutan Pathol; 2019 Sep; 46(9):659-664. PubMed ID: 31012122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of p16 and RB protein in eccrine porocarcinoma.
    Gu LH; Ichiki Y; Kitajima Y
    J Cutan Pathol; 2002 Sep; 29(8):473-9. PubMed ID: 12207741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival.
    Feakins RM; Nickols CD; Bidd H; Walton SJ
    Hum Pathol; 2003 Dec; 34(12):1276-82. PubMed ID: 14691913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival.
    Puduvalli VK; Kyritsis AP; Hess KR; Bondy ML; Fuller GN; Kouraklis GP; Levin VA; Bruner JM
    Int J Oncol; 2000 Nov; 17(5):963-9. PubMed ID: 11029499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.
    Liu Y; Zhong X; Wan S; Zhang W; Lin J; Zhang P; Li Y
    Diagn Pathol; 2014 Dec; 9():180. PubMed ID: 25499675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
    Brambilla E; Moro D; Gazzeri S; Brambilla C
    J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
    Beasley MB; Lantuejoul S; Abbondanzo S; Chu WS; Hasleton PS; Travis WD; Brambilla E
    Hum Pathol; 2003 Feb; 34(2):136-42. PubMed ID: 12612881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The expression of Rb, p16 and cyclin D1 in 41 esophageal cancers].
    Zheng J; Zhou C; Xiao F
    Zhonghua Bing Li Xue Za Zhi; 1996 Dec; 25(6):336-9. PubMed ID: 9388858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
    Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.